1 Study Coverage 1.1 Cephalosporine Product Introduction 1.2 Global Cephalosporine Outlook 2017 VS 2022 VS 2028 1.2.1 Global Cephalosporine Sales in US$ Million for the Year 2017-2028 1.2.2 Global Cephalosporine Sales in Volume for the Year 2017-2028 1.3 United States Cephalosporine Outlook 2017 VS 2022 VS 2028 1.3.1 United States Cephalosporine Sales in US$ Million for the Year 2017-2028 1.3.2 United States Cephalosporine Sales in Volume for the Year 2017-2028 1.4 Cephalosporine Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Cephalosporine in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Cephalosporine Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Cephalosporine Market Dynamics 1.5.1 Cephalosporine Industry Trends 1.5.2 Cephalosporine Market Drivers 1.5.3 Cephalosporine Market Challenges 1.5.4 Cephalosporine Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Cephalosporine Market Segment by Type 2.1.1 First Generation 2.1.2 Second Generation 2.1.3 Third Generation 2.1.4 Fourth Generation 2.2 Global Cephalosporine Market Size by Type 2.2.1 Global Cephalosporine Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Cephalosporine Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Cephalosporine Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Cephalosporine Market Size by Type 2.3.1 United States Cephalosporine Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Cephalosporine Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Cephalosporine Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Cephalosporine Market Segment by Application 3.1.1 Oral 3.1.2 Injection 3.2 Global Cephalosporine Market Size by Application 3.2.1 Global Cephalosporine Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Cephalosporine Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Cephalosporine Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Cephalosporine Market Size by Application 3.3.1 United States Cephalosporine Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Cephalosporine Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Cephalosporine Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Cephalosporine Competitor Landscape by Company 4.1 Global Cephalosporine Market Size by Company 4.1.1 Top Global Cephalosporine Manufacturers Ranked by Revenue (2021) 4.1.2 Global Cephalosporine Revenue by Manufacturer (2017-2022) 4.1.3 Global Cephalosporine Sales by Manufacturer (2017-2022) 4.1.4 Global Cephalosporine Price by Manufacturer (2017-2022) 4.2 Global Cephalosporine Concentration Ratio (CR) 4.2.1 Cephalosporine Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Cephalosporine in 2021 4.2.3 Global Cephalosporine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Cephalosporine Manufacturing Base Distribution, Product Type 4.3.1 Global Cephalosporine Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Cephalosporine Product Type 4.3.3 Date of International Manufacturers Enter into Cephalosporine Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Cephalosporine Market Size by Company 4.5.1 Top Cephalosporine Players in United States, Ranked by Revenue (2021) 4.5.2 United States Cephalosporine Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Cephalosporine Sales by Players (2020, 2021 & 2022) 5 Global Cephalosporine Market Size by Region 5.1 Global Cephalosporine Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Cephalosporine Market Size in Volume by Region (2017-2028) 5.2.1 Global Cephalosporine Sales in Volume by Region: 2017-2022 5.2.2 Global Cephalosporine Sales in Volume Forecast by Region (2023-2028) 5.3 Global Cephalosporine Market Size in Value by Region (2017-2028) 5.3.1 Global Cephalosporine Sales in Value by Region: 2017-2022 5.3.2 Global Cephalosporine Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Cephalosporine Market Size YoY Growth 2017-2028 6.1.2 North America Cephalosporine Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Cephalosporine Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Cephalosporine Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Cephalosporine Market Size YoY Growth 2017-2028 6.3.2 Europe Cephalosporine Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Cephalosporine Market Size YoY Growth 2017-2028 6.4.2 Latin America Cephalosporine Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Cephalosporine Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Cephalosporine Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Union Chempharma 7.1.1 Union Chempharma Corporation Information 7.1.2 Union Chempharma Description and Business Overview 7.1.3 Union Chempharma Cephalosporine Sales, Revenue and Gross Margin (2017-2022) 7.1.4 Union Chempharma Cephalosporine Products Offered 7.1.5 Union Chempharma Recent Development 7.2 NCPC 7.2.1 NCPC Corporation Information 7.2.2 NCPC Description and Business Overview 7.2.3 NCPC Cephalosporine Sales, Revenue and Gross Margin (2017-2022) 7.2.4 NCPC Cephalosporine Products Offered 7.2.5 NCPC Recent Development 7.3 Qilu Antibiotics 7.3.1 Qilu Antibiotics Corporation Information 7.3.2 Qilu Antibiotics Description and Business Overview 7.3.3 Qilu Antibiotics Cephalosporine Sales, Revenue and Gross Margin (2017-2022) 7.3.4 Qilu Antibiotics Cephalosporine Products Offered 7.3.5 Qilu Antibiotics Recent Development 7.4 Lupin Pharmaceuticals 7.4.1 Lupin Pharmaceuticals Corporation Information 7.4.2 Lupin Pharmaceuticals Description and Business Overview 7.4.3 Lupin Pharmaceuticals Cephalosporine Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Lupin Pharmaceuticals Cephalosporine Products Offered 7.4.5 Lupin Pharmaceuticals Recent Development 7.5 Hospira 7.5.1 Hospira Corporation Information 7.5.2 Hospira Description and Business Overview 7.5.3 Hospira Cephalosporine Sales, Revenue and Gross Margin (2017-2022) 7.5.4 Hospira Cephalosporine Products Offered 7.5.5 Hospira Recent Development 7.6 Dhanuka Laboratories 7.6.1 Dhanuka Laboratories Corporation Information 7.6.2 Dhanuka Laboratories Description and Business Overview 7.6.3 Dhanuka Laboratories Cephalosporine Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Dhanuka Laboratories Cephalosporine Products Offered 7.6.5 Dhanuka Laboratories Recent Development 7.7 Fukang 7.7.1 Fukang Corporation Information 7.7.2 Fukang Description and Business Overview 7.7.3 Fukang Cephalosporine Sales, Revenue and Gross Margin (2017-2022) 7.7.4 Fukang Cephalosporine Products Offered 7.7.5 Fukang Recent Development 7.8 Dongying Pharmaceutical 7.8.1 Dongying Pharmaceutical Corporation Information 7.8.2 Dongying Pharmaceutical Description and Business Overview 7.8.3 Dongying Pharmaceutical Cephalosporine Sales, Revenue and Gross Margin (2017-2022) 7.8.4 Dongying Pharmaceutical Cephalosporine Products Offered 7.8.5 Dongying Pharmaceutical Recent Development 7.9 Alkem 7.9.1 Alkem Corporation Information 7.9.2 Alkem Description and Business Overview 7.9.3 Alkem Cephalosporine Sales, Revenue and Gross Margin (2017-2022) 7.9.4 Alkem Cephalosporine Products Offered 7.9.5 Alkem Recent Development 7.10 SALUBRIS 7.10.1 SALUBRIS Corporation Information 7.10.2 SALUBRIS Description and Business Overview 7.10.3 SALUBRIS Cephalosporine Sales, Revenue and Gross Margin (2017-2022) 7.10.4 SALUBRIS Cephalosporine Products Offered 7.10.5 SALUBRIS Recent Development 7.11 LIVZON 7.11.1 LIVZON Corporation Information 7.11.2 LIVZON Description and Business Overview 7.11.3 LIVZON Cephalosporine Sales, Revenue and Gross Margin (2017-2022) 7.11.4 LIVZON Cephalosporine Products Offered 7.11.5 LIVZON Recent Development 7.12 Hetero Drugs 7.12.1 Hetero Drugs Corporation Information 7.12.2 Hetero Drugs Description and Business Overview 7.12.3 Hetero Drugs Cephalosporine Sales, Revenue and Gross Margin (2017-2022) 7.12.4 Hetero Drugs Products Offered 7.12.5 Hetero Drugs Recent Development 7.13 CSPC 7.13.1 CSPC Corporation Information 7.13.2 CSPC Description and Business Overview 7.13.3 CSPC Cephalosporine Sales, Revenue and Gross Margin (2017-2022) 7.13.4 CSPC Products Offered 7.13.5 CSPC Recent Development 7.14 TEVA 7.14.1 TEVA Corporation Information 7.14.2 TEVA Description and Business Overview 7.14.3 TEVA Cephalosporine Sales, Revenue and Gross Margin (2017-2022) 7.14.4 TEVA Products Offered 7.14.5 TEVA Recent Development 7.15 Orchid Pharma 7.15.1 Orchid Pharma Corporation Information 7.15.2 Orchid Pharma Description and Business Overview 7.15.3 Orchid Pharma Cephalosporine Sales, Revenue and Gross Margin (2017-2022) 7.15.4 Orchid Pharma Products Offered 7.15.5 Orchid Pharma Recent Development 7.16 Taj Pharmaceuticals 7.16.1 Taj Pharmaceuticals Corporation Information 7.16.2 Taj Pharmaceuticals Description and Business Overview 7.16.3 Taj Pharmaceuticals Cephalosporine Sales, Revenue and Gross Margin (2017-2022) 7.16.4 Taj Pharmaceuticals Products Offered 7.16.5 Taj Pharmaceuticals Recent Development 7.17 Covalent Laboratories 7.17.1 Covalent Laboratories Corporation Information 7.17.2 Covalent Laboratories Description and Business Overview 7.17.3 Covalent Laboratories Cephalosporine Sales, Revenue and Gross Margin (2017-2022) 7.17.4 Covalent Laboratories Products Offered 7.17.5 Covalent Laboratories Recent Development 7.18 United Laboratories 7.18.1 United Laboratories Corporation Information 7.18.2 United Laboratories Description and Business Overview 7.18.3 United Laboratories Cephalosporine Sales, Revenue and Gross Margin (2017-2022) 7.18.4 United Laboratories Products Offered 7.18.5 United Laboratories Recent Development 7.19 Aurobindo 7.19.1 Aurobindo Corporation Information 7.19.2 Aurobindo Description and Business Overview 7.19.3 Aurobindo Cephalosporine Sales, Revenue and Gross Margin (2017-2022) 7.19.4 Aurobindo Products Offered 7.19.5 Aurobindo Recent Development 7.20 Wockhardt 7.20.1 Wockhardt Corporation Information 7.20.2 Wockhardt Description and Business Overview 7.20.3 Wockhardt Cephalosporine Sales, Revenue and Gross Margin (2017-2022) 7.20.4 Wockhardt Products Offered 7.20.5 Wockhardt Recent Development 7.21 LKPC 7.21.1 LKPC Corporation Information 7.21.2 LKPC Description and Business Overview 7.21.3 LKPC Cephalosporine Sales, Revenue and Gross Margin (2017-2022) 7.21.4 LKPC Products Offered 7.21.5 LKPC Recent Development 7.22 HPGC 7.22.1 HPGC Corporation Information 7.22.2 HPGC Description and Business Overview 7.22.3 HPGC Cephalosporine Sales, Revenue and Gross Margin (2017-2022) 7.22.4 HPGC Products Offered 7.22.5 HPGC Recent Development 7.23 Huafangpharm 7.23.1 Huafangpharm Corporation Information 7.23.2 Huafangpharm Description and Business Overview 7.23.3 Huafangpharm Cephalosporine Sales, Revenue and Gross Margin (2017-2022) 7.23.4 Huafangpharm Products Offered 7.23.5 Huafangpharm Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Cephalosporine Industry Chain Analysis 8.2 Cephalosporine Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Cephalosporine Distributors 8.3 Cephalosporine Production Mode & Process 8.4 Cephalosporine Sales and Marketing 8.4.1 Cephalosporine Sales Channels 8.4.2 Cephalosporine Distributors 8.5 Cephalosporine Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer

List of Tables Table 1. Cephalosporine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Cephalosporine Market Trends Table 3. Cephalosporine Market Drivers Table 4. Cephalosporine Market Challenges Table 5. Cephalosporine Market Restraints Table 6. Global Cephalosporine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Cephalosporine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Cephalosporine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Cephalosporine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Cephalosporine Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Cephalosporine Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Cephalosporine Revenue Share by Manufacturer, 2017-2022 Table 13. Global Cephalosporine Sales by Manufacturer, (Kiloton), 2017-2022 Table 14. Global Cephalosporine Sales Share by Manufacturer, 2017-2022 Table 15. Global Cephalosporine Price by Manufacturer (2017-2022) & (US$/Ton) Table 16. Global Cephalosporine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Cephalosporine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cephalosporine as of 2021) Table 18. Top Players of Cephalosporine in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Cephalosporine Product Type Table 20. Date of International Manufacturers Enter into Cephalosporine Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Cephalosporine Players in United States Market, Ranking by Revenue (2021) Table 23. United States Cephalosporine Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Cephalosporine Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Cephalosporine Sales by Players, (Kiloton), 2020, 2021 & 2022 Table 26. United States Cephalosporine Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Cephalosporine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Cephalosporine Sales in Volume by Region (2017-2022) & (Kiloton) Table 29. Global Cephalosporine Sales in Volume Forecast by Region (2023-2028) & (Kiloton) Table 30. Global Cephalosporine Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Cephalosporine Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Cephalosporine Sales in Volume by Country (2017-2028) & (Kiloton) Table 33. North America Cephalosporine Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Cephalosporine Sales in Volume by Region (2017-2028) & (Kiloton) Table 35. Asia Pacific Cephalosporine Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Cephalosporine Sales in Volume by Country (2017-2028) & (Kiloton) Table 37. Europe Cephalosporine Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Cephalosporine Sales in Volume by Country (2017-2028) & (Kiloton) Table 39. Latin Americaa Cephalosporine Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Cephalosporine Sales in Volume by Country (2017-2028) & (Kiloton) Table 41. Middle East and Africa Cephalosporine Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Union Chempharma Corporation Information Table 43. Union Chempharma Description and Business Overview Table 44. Union Chempharma Cephalosporine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 45. Union Chempharma Cephalosporine Product Table 46. Union Chempharma Recent Development Table 47. NCPC Corporation Information Table 48. NCPC Description and Business Overview Table 49. NCPC Cephalosporine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 50. NCPC Product Table 51. NCPC Recent Development Table 52. Qilu Antibiotics Corporation Information Table 53. Qilu Antibiotics Description and Business Overview Table 54. Qilu Antibiotics Cephalosporine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 55. Qilu Antibiotics Product Table 56. Qilu Antibiotics Recent Development Table 57. Lupin Pharmaceuticals Corporation Information Table 58. Lupin Pharmaceuticals Description and Business Overview Table 59. Lupin Pharmaceuticals Cephalosporine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 60. Lupin Pharmaceuticals Product Table 61. Lupin Pharmaceuticals Recent Development Table 62. Hospira Corporation Information Table 63. Hospira Description and Business Overview Table 64. Hospira Cephalosporine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 65. Hospira Product Table 66. Hospira Recent Development Table 67. Dhanuka Laboratories Corporation Information Table 68. Dhanuka Laboratories Description and Business Overview Table 69. Dhanuka Laboratories Cephalosporine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 70. Dhanuka Laboratories Product Table 71. Dhanuka Laboratories Recent Development Table 72. Fukang Corporation Information Table 73. Fukang Description and Business Overview Table 74. Fukang Cephalosporine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 75. Fukang Product Table 76. Fukang Recent Development Table 77. Dongying Pharmaceutical Corporation Information Table 78. Dongying Pharmaceutical Description and Business Overview Table 79. Dongying Pharmaceutical Cephalosporine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 80. Dongying Pharmaceutical Product Table 81. Dongying Pharmaceutical Recent Development Table 82. Alkem Corporation Information Table 83. Alkem Description and Business Overview Table 84. Alkem Cephalosporine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 85. Alkem Product Table 86. Alkem Recent Development Table 87. SALUBRIS Corporation Information Table 88. SALUBRIS Description and Business Overview Table 89. SALUBRIS Cephalosporine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 90. SALUBRIS Product Table 91. SALUBRIS Recent Development Table 92. LIVZON Corporation Information Table 93. LIVZON Description and Business Overview Table 94. LIVZON Cephalosporine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 95. LIVZON Product Table 96. LIVZON Recent Development Table 97. Hetero Drugs Corporation Information Table 98. Hetero Drugs Description and Business Overview Table 99. Hetero Drugs Cephalosporine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 100. Hetero Drugs Product Table 101. Hetero Drugs Recent Development Table 102. CSPC Corporation Information Table 103. CSPC Description and Business Overview Table 104. CSPC Cephalosporine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 105. CSPC Product Table 106. CSPC Recent Development Table 107. TEVA Corporation Information Table 108. TEVA Description and Business Overview Table 109. TEVA Cephalosporine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 110. TEVA Product Table 111. TEVA Recent Development Table 112. Orchid Pharma Corporation Information Table 113. Orchid Pharma Description and Business Overview Table 114. Orchid Pharma Cephalosporine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 115. Orchid Pharma Product Table 116. Orchid Pharma Recent Development Table 117. Taj Pharmaceuticals Corporation Information Table 118. Taj Pharmaceuticals Description and Business Overview Table 119. Taj Pharmaceuticals Cephalosporine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 120. Taj Pharmaceuticals Product Table 121. Taj Pharmaceuticals Recent Development Table 122. Covalent Laboratories Corporation Information Table 123. Covalent Laboratories Description and Business Overview Table 124. Covalent Laboratories Cephalosporine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 125. Covalent Laboratories Product Table 126. Covalent Laboratories Recent Development Table 127. United Laboratories Corporation Information Table 128. United Laboratories Description and Business Overview Table 129. United Laboratories Cephalosporine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 130. United Laboratories Product Table 131. United Laboratories Recent Development Table 132. Aurobindo Corporation Information Table 133. Aurobindo Description and Business Overview Table 134. Aurobindo Cephalosporine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 135. Aurobindo Product Table 136. Aurobindo Recent Development Table 137. Wockhardt Corporation Information Table 138. Wockhardt Description and Business Overview Table 139. Wockhardt Cephalosporine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 140. Wockhardt Product Table 141. Wockhardt Recent Development Table 142. LKPC Corporation Information Table 143. LKPC Description and Business Overview Table 144. LKPC Cephalosporine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 145. LKPC Product Table 146. LKPC Recent Development Table 147. HPGC Corporation Information Table 148. HPGC Description and Business Overview Table 149. HPGC Cephalosporine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 150. HPGC Product Table 151. HPGC Recent Development Table 152. Huafangpharm Corporation Information Table 153. Huafangpharm Description and Business Overview Table 154. Huafangpharm Cephalosporine Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 155. Huafangpharm Product Table 156. Huafangpharm Recent Development Table 157. Key Raw Materials Lists Table 158. Raw Materials Key Suppliers Lists Table 159. Cephalosporine Customers List Table 160. Cephalosporine Distributors List Table 161. Research Programs/Design for This Report Table 162. Key Data Information from Secondary Sources Table 163. Key Data Information from Primary Sources List of Figures Figure 1. Cephalosporine Product Picture Figure 2. Global Cephalosporine Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Cephalosporine Market Size 2017-2028 (US$ Million) Figure 4. Global Cephalosporine Sales 2017-2028 (Kiloton) Figure 5. United States Cephalosporine Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Cephalosporine Market Size 2017-2028 (US$ Million) Figure 7. United States Cephalosporine Sales 2017-2028 (Kiloton) Figure 8. United States Cephalosporine Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Cephalosporine Market Share in Global, in Volume (Kiloton) 2017-2028 Figure 10. Cephalosporine Report Years Considered Figure 11. Product Picture of First Generation Figure 12. Product Picture of Second Generation Figure 13. Product Picture of Third Generation Figure 14. Product Picture of Fourth Generation Figure 15. Global Cephalosporine Market Share by Type in 2022 & 2028 Figure 16. Global Cephalosporine Sales in Value by Type (2017-2028) & (US$ Million) Figure 17. Global Cephalosporine Sales Market Share in Value by Type (2017-2028) Figure 18. Global Cephalosporine Sales by Type (2017-2028) & (Kiloton) Figure 19. Global Cephalosporine Sales Market Share in Volume by Type (2017-2028) Figure 20. Global Cephalosporine Price by Type (2017-2028) & (US$/Ton) Figure 21. United States Cephalosporine Market Share by Type in 2022 & 2028 Figure 22. United States Cephalosporine Sales in Value by Type (2017-2028) & (US$ Million) Figure 23. United States Cephalosporine Sales Market Share in Value by Type (2017-2028) Figure 24. United States Cephalosporine Sales by Type (2017-2028) & (Kiloton) Figure 25. United States Cephalosporine Sales Market Share in Volume by Type (2017-2028) Figure 26. United States Cephalosporine Price by Type (2017-2028) & (US$/Ton) Figure 27. Product Picture of Oral Figure 28. Product Picture of Injection Figure 29. Global Cephalosporine Market Share by Application in 2022 & 2028 Figure 30. Global Cephalosporine Sales in Value by Application (2017-2028) & (US$ Million) Figure 31. Global Cephalosporine Sales Market Share in Value by Application (2017-2028) Figure 32. Global Cephalosporine Sales by Application (2017-2028) & (Kiloton) Figure 33. Global Cephalosporine Sales Market Share in Volume by Application (2017-2028) Figure 34. Global Cephalosporine Price by Application (2017-2028) & (US$/Ton) Figure 35. United States Cephalosporine Market Share by Application in 2022 & 2028 Figure 36. United States Cephalosporine Sales in Value by Application (2017-2028) & (US$ Million) Figure 37. United States Cephalosporine Sales Market Share in Value by Application (2017-2028) Figure 38. United States Cephalosporine Sales by Application (2017-2028) & (Kiloton) Figure 39. United States Cephalosporine Sales Market Share in Volume by Application (2017-2028) Figure 40. United States Cephalosporine Price by Application (2017-2028) & (US$/Ton) Figure 41. North America Cephalosporine Sales in Volume Growth Rate 2017-2028 (Kiloton) Figure 42. North America Cephalosporine Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 43. U.S. Cephalosporine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 44. Canada Cephalosporine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 45. Europe Cephalosporine Sales in Volume Growth Rate 2017-2028 (Kiloton) Figure 46. Europe Cephalosporine Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 47. Germany Cephalosporine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. France Cephalosporine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. U.K. Cephalosporine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. Italy Cephalosporine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. Russia Cephalosporine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 52. Asia-Pacific Cephalosporine Sales in Volume Growth Rate 2017-2028 (Kiloton) Figure 53. Asia-Pacific Cephalosporine Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 54. China Cephalosporine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. Japan Cephalosporine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. South Korea Cephalosporine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. India Cephalosporine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. Australia Cephalosporine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Taiwan Cephalosporine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Indonesia Cephalosporine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Thailand Cephalosporine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Malaysia Cephalosporine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Philippines Cephalosporine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 64. Latin America Cephalosporine Sales in Volume Growth Rate 2017-2028 (Kiloton) Figure 65. Latin America Cephalosporine Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 66. Mexico Cephalosporine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Brazil Cephalosporine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 68. Argentina Cephalosporine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 69. Middle East & Africa Cephalosporine Sales in Volume Growth Rate 2017-2028 (Kiloton) Figure 70. Middle East & Africa Cephalosporine Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 71. Turkey Cephalosporine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 72. Saudi Arabia Cephalosporine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 73. U.A.E Cephalosporine Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 74. Cephalosporine Value Chain Figure 75. Cephalosporine Production Process Figure 76. Channels of Distribution Figure 77. Distributors Profiles Figure 78. Bottom-up and Top-down Approaches for This Report Figure 79. Data Triangulation Figure 80. Key Executives Interviewed

Union Chempharma NCPC Qilu Antibiotics Lupin Pharmaceuticals Hospira Dhanuka Laboratories Fukang Dongying Pharmaceutical Alkem SALUBRIS LIVZON Hetero Drugs CSPC TEVA Orchid Pharma Taj Pharmaceuticals Covalent Laboratories United Laboratories Aurobindo Wockhardt LKPC HPGC Huafangpharm